Best supportive care (BSC) is generally defined as all the interventions and the multiprofessional approach aimed to improve and optimise quality of life (QoL) in patients affected by progressive diseases. In this sense, it excludes and might be complementary to other interventions directly targeting the disease. BSC improves survival in patients with different types of cancer. Patients with idiopathic pulmonary fibrosis (IPF) experience a vast range of symptoms during the natural history of the disease and might have a beneficial effect of BSC interventions. This review highlights the current evidence on interventions targeting QoL and gaps for the clinical assessment of BSC in the treatment of IPF patients. Very few interventions to improve QoL or improve symptom control are currently supported by well-designed studies. Sound methodology is paramount in evaluating BSC in IPF, as well as the use of validated tools to measure QoL and symptom control in this specific group of patients.

Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions / Ferrara, Giovanni; Luppi, Fabrizio; Birring, Surinder S.; Cerri, Stefania; Caminati, Antonella; Sköld, Magnus; Kreuter, Michael. - In: EUROPEAN RESPIRATORY REVIEW. - ISSN 0905-9180. - 27:147(2018), pp. 170076-170076. [10.1183/16000617.0076-2017]

Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions

Luppi, Fabrizio;Cerri, Stefania;
2018

Abstract

Best supportive care (BSC) is generally defined as all the interventions and the multiprofessional approach aimed to improve and optimise quality of life (QoL) in patients affected by progressive diseases. In this sense, it excludes and might be complementary to other interventions directly targeting the disease. BSC improves survival in patients with different types of cancer. Patients with idiopathic pulmonary fibrosis (IPF) experience a vast range of symptoms during the natural history of the disease and might have a beneficial effect of BSC interventions. This review highlights the current evidence on interventions targeting QoL and gaps for the clinical assessment of BSC in the treatment of IPF patients. Very few interventions to improve QoL or improve symptom control are currently supported by well-designed studies. Sound methodology is paramount in evaluating BSC in IPF, as well as the use of validated tools to measure QoL and symptom control in this specific group of patients.
27
147
170076
170076
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions / Ferrara, Giovanni; Luppi, Fabrizio; Birring, Surinder S.; Cerri, Stefania; Caminati, Antonella; Sköld, Magnus; Kreuter, Michael. - In: EUROPEAN RESPIRATORY REVIEW. - ISSN 0905-9180. - 27:147(2018), pp. 170076-170076. [10.1183/16000617.0076-2017]
Ferrara, Giovanni; Luppi, Fabrizio; Birring, Surinder S.; Cerri, Stefania; Caminati, Antonella; Sköld, Magnus; Kreuter, Michael
File in questo prodotto:
File Dimensione Formato  
170076.full.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 334.92 kB
Formato Adobe PDF
334.92 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1154313
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 25
social impact